FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean Rodgers

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Anatomy

Brain

Geographic Areas

Africa South of the Sahara

Concepts & Ideas

Physiology

Blood-Brain Barrier

Co-author Network

Publications

TOP 3
Jean Rodgers; Christopher McCabe; Michael P Barrett; Barbara Bradley; George Gettinby; Stéphane Gibaud; Amy Jones; Peter G E Kennedy
Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis.
Jean Rodgers
Human African trypanosomiasis, chemotherapy and CNS disease.
Jean Rodgers; Trevor W Stone; Michael P Barrett; Barbara Bradley; Peter G E Kennedy
Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean Rodgers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Jean Rodgers; Christopher McCabe; Michael P Barrett; Barbara Bradley; George Gettinby; Stéphane Gibaud; Amy Jones; Peter G E Kennedy
Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis.
PLoS neglected tropical diseases 2011;5(9):e1308.
2009: Jean Rodgers
Human African trypanosomiasis, chemotherapy and CNS disease.
Journal of neuroimmunology 2009;211(1-2):16-22.
2009: Jean Rodgers; Trevor W Stone; Michael P Barrett; Barbara Bradley; Peter G E Kennedy
Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis.
Brain : a journal of neurology 2009;132(Pt 5):1259-67.
2007: Jean Rodgers; Barbara Bradley; Peter G E Kennedy
Combination chemotherapy with a substance P receptor antagonist (aprepitant) and melarsoprol in a mouse model of human African trypanosomiasis.
Parasitology international 2007;56(4):321-4.
2005: Jeremy M Sternberg; Jean Rodgers; Barbara Bradley; Lorna MacLean; Max Murray; Peter G E Kennedy
Meningoencephalitic African trypanosomiasis: Brain IL-10 and IL-6 are associated with protection from neuro-inflammatory pathology.
Journal of neuroimmunology 2005;167(1-2):81-9.
2003: Peter G E Kennedy; Jean Rodgers; Barbara Bradley; Stephen P Hunt; George Gettinby; Susan E Leeman; Carmen De Felipe; Max Murray
Clinical and neuroinflammatory responses to meningoencephalitis in substance P receptor knockout mice.
Brain : a journal of neurology 2003;126(Pt 7):1683-90.
2002: Frank W Jennings; Jean Rodgers; Barbara Bradley; George Gettinby; Peter G E Kennedy; Max Murray
Human African trypanosomiasis: potential therapeutic benefits of an alternative suramin and melarsoprol regimen.
Parasitology international 2002;51(4):381-8.
2002: Peter G E Kennedy; Max Murray; Frank W Jennings; Jean Rodgers
Sleeping sickness: new drugs from old? [corrected].
Lancet 2002;359(9318):1695-6.
2001: Peter David Eckersall; JW Gow; C McComb; Barbara Bradley; Jean Rodgers; Max Murray; Peter G E Kennedy
Cytokines and the acute phase response in post-treatment reactive encephalopathy of Trypanosoma brucei brucei infected mice.
Parasitology international 2001;50(1):15-26.
1999: Peter David Eckersall; Jean Rodgers; M Murray; Peter G E Kennedy
Haptoglobin, the acute phase response and natural human immunity to trypanosomes.
Parasitology today (Personal ed.) 1999;15(6):251-2.
1997: Frank W Jennings; C W Gichuki; Peter G E Kennedy; Jean Rodgers; C A Hunter; Max Murray; J M Burke
The role of the polyamine inhibitor eflornithine in the neuropathogenesis of experimental murine African trypanosomiasis.
Neuropathology and applied neurobiology 1997;23(3):225-34.
1997: Peter G E Kennedy; Jean Rodgers; Frank W Jennings; Max Murray; S E Leeman; J M Burke
A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(8):4167-70.